RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Vertex Pharmaceuticals
V

Vertex Pharmaceuticals portfolio

Vertex Pharmaceuticals has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $289M.
Latest deal: Arbor Biotechnologies · Mar 18, 2025.
About this page

Its most recent investment on record is Arbor Biotechnologies's $74M Series B+ round in March 2025, alongside Partners Investment, Qatar Investment Authority, TCG Crossover and 6 others. That company is in Health and bio. It has co-invested with T. Rowe Price, Temasek and TCG Crossover, most often T. Rowe Price (2 rounds).

What Vertex Pharmaceuticals invests in

How Vertex Pharmaceuticals invests

StageDealsCapital in rounds
Series B+ 2 100%$289M
YearDealsCapital in rounds
2021 1 50%$215M
2025 1 50%$74M

Vertex Pharmaceuticals portfolio companies

CompanyRound with Vertex PharmaceuticalsTotal raisedLatest raise
AArbor Biotechnologies
Health and bio
 Series B+ · $74M$289MMar 18, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Vertex Pharmaceuticals. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Vertex Pharmaceuticals, which is a subset of its real portfolio. API: /api/v1/investors/vertex-pharmaceuticals (get a free API key). More: the most active VC firms and new venture capital funds.